Study reveals that reversible chemical modifications can inhibit pyruvate kinase and affect its variants differently, ...

Modeling the economic impact of a CIZ1B biomarker blood test for lung cancer screening in high-risk populations. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract ...

By studying immune cell dynamics, this postdoctoral researcher aims to uncover new clinical insights into HIV and sickle cell disease.

A new research paper was published in Volume 13 of Oncoscience on January 28, 2026, titled "Dual targeting of oncogenic microtubules and mitochondria in PDAC." In this study led by first author ...

Cancer is one of the leading causes of death worldwide, marked by the uncontrolled growth of abnormal cells. What makes it more dangerous is the ability of cancer cells to move quickly through the ...

Researchers identify beta catenin protein degradation as a therapeutic vulnerability in B cell acute lymphoblastic leukaemia, supporting the repurposing of glycogen synthase kinase 3 beta inhibitors.

Two new lines of brain research are testing whether aging cells can be nudged into working more like young ones. In one study, scientists boosted a protein called cyclin D-binding myb-like ...

A groundbreaking phase 2 trial explores a novel, chemotherapy-free immunotherapy for relapsed indolent B-cell lymphomas, aiming to enhance patient outcomes.